James Paul Scopa, Director at Adverum Biotechnologies, Inc. (ADVM), sold 100,000 shares at $2.18 ($218K) on 2021-11-15, disclosed to the SEC on 2021-11-17.
Open-market sale of $218k ADVM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.18 | 50,000 | $109K | 50.0% |
| 2 | $2.18 | 50,000 | $109K | 50.0% |
| Total | $2.18 avg | 100,000 | $218K | 100% |
| Filing → |
| DICE | BUY | 2021-09-16 | $102K | — | Filing → |
| ADVM | BUY | 2020-02-14 | $138K | — | Filing → |
| ADVM | BUY | 2019-05-06 | $134K | — | Filing → |